The use of metformin among people with type 2 diabetes who have chronic kidney disease (CKD) is associated with a reduced risk of death and end-stage renal disease (ESRD) — without increasing the risk ...
Please provide your email address to receive an email when new articles are posted on . The rate of exacerbation was 46.8% in the group using metformin and 63% in the group not using metformin. The ...
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes. Editor's Note: The information ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Women with type 2 diabetes and those who ...
Metformin, statin and aspirin use seem associated with decreased mortality in cancer patients, though, without adjusting for one another. Independent associations of these drugs with overall mortality ...
(Updated April 11 with commentary) In a response to mounting evidence, the US Food and Drug Administration (FDA) announced that the diabetes drug metformin can be used safely in patients with mild and ...
Results of a case-control study show metformin use may protect against the development of age-related macular degeneration (AMD) in adults 55 years and older, and the association is dose-dependent, ...
The authors note that the only pharmacological instrument that has demonstrated efficacy for preventing AIWG is metformin. HealthDay News — In a guideline published online December 9 in Schizophrenia ...
Metformin use is linked to improved survival rates in patients with ovarian cancer, particularly among those with diabetes and serous cancers, though further research is needed to confirm these ...
Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a new study.
BIRMINGHAM, Ala. - Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results